Press Releases
5 August 2019
Transgene, a biotech company designing and developing virus-based immunotherapies for the treatment of solid tumors, today announces that the independent Data Monitoring Committee (“IDMC&rdqu
Read more...Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM™ RAS CRC Kit, used for blood-based circulating tumor DNA (ctDNA) molecular testing of mutations
Read more...2 August 2019
Bigfoot Biomedical, Inc., and Allegheny Health Network (AHN) – a Highmark Health company – announced today a collaboration to further advance Bigfoot Biomedical’s first-in-kind da
Read more...1 August 2019
MDLIVE Inc., an industry-leading virtual healthcare provider, today announced a strategic and landmark partnership with CoxHealth. MDLIVE’s virtual care platform will be seamlessly integrated
Read more...Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics, today announced Baptist Health (KY), Lehigh Valley Health Network (PA), Marshfield Clinic (WI),
Read more...The full programme of the IoT Solutions World Congress (IoTSWC) is now available. The event organised by Fira de Barcelona in collaboration with the Industrial Internet Consortium (IIC) will presen
Read more...30 July 2019
A new partnership between Gilsbar, one of the nation's largest privately held health and benefits management organizations, and Regenexx, a world-class interventional orthopedic clinic network,
Read more...26 July 2019
AptarGroup, Inc., a global leader in dispensing and drug delivery solutions, today announced that its Unidose Powder System was recently approved by the U.S. Food and Drug Administration (FDA) for
Read more...MUVE Health, a ValueHealth company, the nation's premier value-based outpatient total joint replacement provider announces a new partnership with Quil, the digital health joint venture between
Read more...Curetis N.V., a developer of next-level molecular diagnostic solutions, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration for its Unyvero LRT Lower Resp
Read more...
